Most recent by Isaac Lipshitz, MD
Implante telescópico de espelho pseudofácico pode beneficiar pacientes de DMAI

O Dr. Isaac Lipshitz desenvolveu o telescópio em miniatura implantável (IMT, VisionCare) na década de 90, e o primeiro implante de telescópio de espelho foi o implante macular Lipshitz (LMI, OptoLight). Um implante telescópico intraocular secundário, mais recente, a OriLens (OptoLight), recebeu recentemente a marca CE. Realizamos a primeira cirurgia de LMI e tivemos a honra de ser convidados pelo Dr. Lipshitz para fazer a primeira cirurgia OriLens do mundo. O meu convidado especial nesta coluna é o Dr. Lipshitz.
Implante telescópico en espejo pseudofáquico puede ayudar a los pacientes con DMRE

Isaac Lipshitz desarrolló el Telescopio implantable en miniatura (IMT, VisionCare) en los 90 y el primer implante de telescopio en espejo fue el Lipshitz Macular Implant (LMI, OptoLight). Un implante telescópico intraocular secundario y nuevo, el OriLens (OptoLight), recientemente recibió la marca CE. Realizamos la primera cirugía LMI y fuimos honrados con la propuesta del Dr. Lipshitz para realizar la primera cirugía OriLens en el mundo. Mi invitado especial en esta columna es el Dr. Lipshitz. – Amar Agarwal, MS, FRCS, FRCOphth, Editor para Complications Consult de OSN
Pseudophakic mirror telescopic implant can benefit AMD patients
Low vision, which does not improve with regular spectacle correction, is often seen in older patients with age-related macular degeneration. Improving visual acuity with a telescopic lens has been tried recently. The mirror telescopic IOL magnifies the image only on the central retina. It is designed as a secondary implant for pseudophakic eyes but is used also for primary phakic implantation when a regular IOL is implanted first and the telescopic part is added on during the same procedure.
Sulcus-implanted mirror telescopic IOL helpful for AMD, other macular disorders
With an aging population, there is an increasing population of cataract patients with other associated eye diseases. The difficulties that comorbid pathologies induce are experienced by surgeons all over the world. The prevalence of age-related macular degeneration in Asia is similar to that in Caucasian populations, variously reported as ranging from 1.4% to 12.7% for early AMD and 0.2% to 1.9% for late AMD. The presence of cortical cataract and prior cataract surgery are significantly associated with increased prevalence of AMD, showing that these age-related conditions often coexist.